Protease inhibitor reduces loss of tensile strength in rat anastomosis with peritonitis

Journal of Surgical Research

Volumn 88, Issue 2, 2000, Pages 135-141

  Tani, Tohru ^a   Tsutamoto, Yoshihiro ^a   Eguchi, Yutaka ^a   Araki, Hiroshi ^a   Ebira, Youzou ^a   Ameno, Hiroyuki ^a   Fujino, Mitsuhiro ^a   Oka, Hiroshi ^a   Kodama, Masashi ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

Author keywords

Extracellular matrix; Factor XIII; Fibronectin; Immunohistochemistry; Intestinal anastomosis; Peritonitis; Wound healing

Indexed keywords

BIOTIN; BLOOD CLOTTING FACTOR 13; COLLAGEN FIBER; FIBRONECTIN; FORMALDEHYDE; HYDROCHLORIC ACID; NAFAMSTAT MESILATE; PARAFORMALDEHYDE; PEROXIDASE; SERINE PROTEINASE INHIBITOR; STREPTAVIDIN;

ANASTOMOSIS LEAKAGE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLLAGEN DEGRADATION; CONTROLLED STUDY; EDEMA; EXTRACELLULAR MATRIX; IMMUNOHISTOCHEMISTRY; INTESTINE ANASTOMOSIS; MALE; NONHUMAN; PERITONITIS; PRIORITY JOURNAL; RAT; TENSILE STRENGTH; WOUND HEALING;

EID: 0033969867     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1006/jsre.1999.5765     Document Type: Article

References (16)

1. Jönssön K., Jiborn H., Zederfelt B. Breaking strength of small intestinal anastomoses. Am. J. Surg. 145:1983;800.
2. Högström H., Haglund U. Postoperative decrease in suture holding capacity in laparotomy wounds and anastomoses. Acta Chir. Scand. 151:1985;533.
3. Hawley P. R., Faulk W. P., Hunt T. K. Collagenase activity in the gastrointestinal tract. Br. J. Surg. 57:1970;896.
4. Young H. L., Wheeler M. H. Collagenase inhibition in the healing colon. J. R. Soc. Med. 76:1983;32.
5. Tsutamoto Y., Tani T., Eguchi Y. Protective effect of nafamostat mesilate in early wound healing. J. Am. Coll. Surg. 184:1997;637.
6. Billing A., Frohlich D., Assfalg M. I. Proteolysis of defensive proteins in peritonitis exudate: Pathobiochemical aspects and therapeutical approach. Biomed. Biochim. Acta. 50:1991;399.
7. Hynes R. O., Yamada K. M. Fibrnonectins: Multifunctional modular glycoproteins. J. Cell Biol. 95:1982;369.
8. Grinnell F., Feld M., Minter D. Fibroblast adhesion to fibrinogen and fibrin substrata: Requirement for cold-insoluble globulin (plasma fibronectin). Cell. 19:1980;517.
9. Egbring R., Klingmann H. G. Factor XIII and Fibronectin: New Clinical and Biological Approaches. 1983;Med. Verl. Ges. Marburg.
10. Kasai S., Kunimoto T., Nitta K. Cross-linking of fibrin by activated factor XIII stimulates attachment, morphological changes and proliferation of fibroblasts. Biomed. Res. 4:1983;155.
11. Jönssön T., Högström H. Neutrophil-dependent decrease in early wound margin strength. Arch. Surg. 126:1991;1423.
12. Alitalo K., Vaheri A. Pericellular matrix in malignant transformation. Adv. Cancer Res. 37:1982;111.
13. Murakawa M., Okamura T., Shibuya T. Use of a synthetic protease inhibitor for the treatment of L-asparaginase-induced acute pancreatitis complicated by disseminated intravascular coagulation. Ann. Hematol. 64:1992;249.
14. Hanano M., Takahashi H., Arakawa K. Consumption coagulopathy associated with left atrial thrombosis. Hematol. Pathol. 5:1991;27.
15. Takemoto Y., Tanaka S., Tanabe J. Studies on the effects of primary therapy for DIC following circulatory arrest. Am. J. Hematol. 21:1986;377.
16. Tani T., Endo Y., Yoshioka T. Therapeutic plasmapheresis for post-operative hepatic failure. Prog. Clin. Biol. Res. 337:1990;213.